Michael Braun: The Work Is Not Finished in Sickle Cell Disease
Michael Braun, U.S. Specialty Care President at Pfizer, shared a post on LinkedIn:
“Sickle cell disease affects millions of people worldwide — and still carries the weight of inequity. For too many, the journey is defined not just by pain and crises, but by delayed diagnoses, limited access to specialized care, and treatment options that haven’t kept pace with the urgency.
On World Sickle Cell Day, I’m thinking about a community that has been asked to wait too long for progress — and what it means to truly show up for them.
For our team at Pfizer, that means continuing to advance our research and education in sickle cell disease, supporting scholarships, helping nonprofit organizations in their mission to ease the burden of travel to care, and listening closely to the people most affected.
Progress is possible, and it’s also necessary. Our work isn’t finished.
To everyone living with sickle cell, caring for someone who is, or fighting for change in this community:
Stay updated with Hemostasis Today.
-
Aug 7, 2026, 16:26Shayan Mohammadmoradi: Excited to Co-Chair the 2028 Hemostasis Gordon Research Seminar
-
Aug 7, 2026, 16:04Ayuka King-Percival: Understanding Platelet Aggregation Testing
-
Aug 7, 2026, 15:59Nita Radhakrishnan։ New Evidence-Based Guidelines for Transfusion-Dependent Thalassemia
-
Aug 7, 2026, 15:54Seema Dawood: Why the Peripheral Blood Smear Still Matters in the Age of Automation?
-
Aug 7, 2026, 15:42Mohammed Elmourtada Abdulgayoom։ Caplacizumab-Enabled Treatment of iTTP Without Plasma Exchange
-
Aug 7, 2026, 15:40Renata Evertz: THUNDER Study Sets a New Benchmark in Stroke Thrombectomy
-
Aug 7, 2026, 15:23Ashley Brown: An Incredible Week at the Hemostasis GRC
-
Aug 7, 2026, 15:04Danique Steeghs: Developing a Chip-Sized ADAMTS13 Activity Assay for TTP Point-of-Care Testing
-
Aug 7, 2026, 15:02Mohd Laraib: The Importance of Multidisciplinary Collaboration in the Management of CAPS